Lack of the cytochrome P450 3A interaction of methanolic extract of Withania somnifera, Withaferin A, Withanolide A and Withanoside IV

Journal of Pharmaceutical Negative Results

Volumn 4, Issue 1, 2013, Pages 26-32

  Savai, Jay ^a   Varghese, Alice ^a   Pandita, Nancy ^a  

^a Narsee Monjee Institute of Management Studies   (India)

Author keywords

Cytochrome 3A interaction; human liver microsomes; rat liver microsomes; sildenafil citrate

Indexed keywords

CYTOCHROME P450 3A; METHANOL; PLANT EXTRACT; SILDENAFIL; UNCLASSIFIED DRUG; WITHAFERIN A; WITHANIA SOMNIFERA EXTRACT; WITHANOLIDE A; WITHANOSIDE IV;

ANIMAL CELL; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; IC 50; LIVER MICROSOME; MALE; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; RAT;

EID: 84883667544     PISSN: 09769234     EISSN: 22297723     Source Type: Journal    
DOI: 10.4103/0976-9234.116766     Document Type: Article

References (24)

1. Ponnusankar S, Pandit S, Babu R, Bandyopadhyay A, Mukherjee PK. Cytochrome P450 inhibitory potential of Triphala - a rasayana from Ayurveda. J Ethnopharmacol 2011;133:120-5.
2. Obach SR. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. J Pharmacol Exp Ther 2000;294:88-95.
3. Ho PC, Saville DJ. Inhibition of human CYP3A4 activity by grapefruit flavonoids, furanocoumarins and related compounds. J Pharm Pharm Sci 2001;4:217-27. (Pubitemid 34305597)
4. Jiang B, Cai F, Gao S, Meng L, Liang F, Dai X, et al. Induction of cytochrome P450 3A by ShexiangBaoxin Pill and its main components. Chem Biol Interact 2012;195:105-13.
5. Fasinu PS, Bouic PJ, Rosenkranz B. An overview of the evidence and mechanisms of herb-drug interactions. Front Pharmacol 2012;3:69.
6. Withania somnifera monograph. Altern Med Rev 2004;9:211-4.
7. Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): A review. Altern Med Rev 2000;5:334-46. (Pubitemid 30660827)
8. Bhatnagar M, Sisodia SS, Bhatnagar R. Antiulcer and antioxidant activity of Asparagus racemosa WILLD and Withania somnifera DUNAL in rats. Ann N Y Acad Sci 2005;1056:261-78. (Pubitemid 43030984)
9. Gupta SK, Dua A, Vohra BP. Withania somnifera (ashwagandha) attenuates antioxidant defense in aged spinal cord and inhibits copper induced lipid peroxidation and protein oxidative modifications. Drug Metabol Drug Interact 2003;19:211-22. (Pubitemid 37505163)
10. Bhattacharya A, Ghosal S, Bhattacharya SK. Anti-oxidant effect of Withania somniferaglyco with anolides in chronic footshockstressinduced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum. J Ethnopharmacol 2001;74:1-6. (Pubitemid 32008512)
11. Bhattacharya SK, Satyan KS, Ghosal S. Antioxidant activity of glycowithanolides from Withania somnifera. Indian J Exp Biol 1997;35:236-9. (Pubitemid 28135409)
12. Scartezzini P, Speroni E. Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol 2007;71:23-43.
13. Murthy V, Ranjekar MR, Ramassamy PK, Deshpande C. Scientific basis for the use of Indian ayurvedic medicinal plants in the treatment of neurodegenerative disorders: Ashwagandha. Cent Nerv Syst Agents Med Chem 2010;10:238-46.
14. Ahmad MK, Mahdi AA, Shukla KK, Islam N, Rajender S, Madhukar D, et al. Withania somnifera improves semen quality by regulating reproductive hormone levels and oxidative stress in seminal plasma of infertile males. Fertil Steril 2010;94:989-96.
15. Cooley K, Szczurko O, Perri D, Mills EJ, Bernhardt B, Zhou Q, et al. Naturopathic care for anxiety: A randomized controlled trial ISRCTN78958974. PLoS One 2009;4:e6628.
16. Lakshmi M, Betsy B, Simon D. Basis for the therapeutic use of Withania somnifera (Ashwagandha). Altern Med Rev 2000;5:334-46.
17. Pradnya S, Walawalkar PS, Serai, Iyer KR. Isolation and catalytic competence of different animal liver microsomal fractions prepared by calcium - aggregation method. Indian J Pharm Sci 2006;68:262-5.
18. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin Phenol Reagent. J Biol Chem 1951;193:265-75.
19. Guidance for Industry Drug Interactions Studies; US-FDA. Clin Pharmacol 2006; Available from http://www.fda.gov/OHRMS/DOCKETS/98fr/06d-0344-gdl0001.pdf (guidelines)
20. Abboot D, Comby P, Charuel C, Graepel P, Hanton G, Leblanc B, et al. Preclinical safety profile of Sildenafil citrate. Int J Impot Res 2004;16:498-504. (Pubitemid 39664857)
21. Girdhari G, Avtar R. Protective effect of Withania somnifera Dunal root extract against protracted social isolation induced behavior in rats. Indian J Physiol Pharmacol 2007;51:345-53.
22. Kessler RC, Davis RB, Foster DF, Walters EE, Wilkey SA, Kaptchuk TJ, et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 2001;135:262-8. (Pubitemid 32799340)
23. Singh S, Kumar S. Withania somnifera: The Indian Ginseng Ashwagandha. Central Institute of Medicinal and Aromatic Plants. Lucknow, India (book).1998.
24. Mohammed H, Elisabeth M, Mercedes B, Cusido RM, Palazón J. Steroidal Lactones from Withania somnifera, an Ancient Plant for Novel Medicine. Molecules 2009;14:2373-93.